nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—ADRA2C—Brimonidine—glaucoma	0.0573	0.0632	CbGbCtD
Methotrimeprazine—ADRA2C—Apraclonidine—glaucoma	0.0573	0.0632	CbGbCtD
Methotrimeprazine—ADRA2B—Brimonidine—glaucoma	0.0544	0.06	CbGbCtD
Methotrimeprazine—ADRA2B—Apraclonidine—glaucoma	0.0544	0.06	CbGbCtD
Methotrimeprazine—ADRA2C—Dipivefrin—glaucoma	0.0458	0.0505	CbGbCtD
Methotrimeprazine—ADRA2B—Dipivefrin—glaucoma	0.0435	0.0479	CbGbCtD
Methotrimeprazine—CHRM3—Carbachol—glaucoma	0.0394	0.0434	CbGbCtD
Methotrimeprazine—ADRA2A—Apraclonidine—glaucoma	0.0378	0.0417	CbGbCtD
Methotrimeprazine—ADRA2A—Brimonidine—glaucoma	0.0378	0.0417	CbGbCtD
Methotrimeprazine—CHRM3—Pilocarpine—glaucoma	0.0366	0.0403	CbGbCtD
Methotrimeprazine—ADRA1A—Apraclonidine—glaucoma	0.0363	0.04	CbGbCtD
Methotrimeprazine—CHRM1—Carbachol—glaucoma	0.0342	0.0377	CbGbCtD
Methotrimeprazine—CHRM1—Pilocarpine—glaucoma	0.0318	0.0351	CbGbCtD
Methotrimeprazine—CHRM2—Carbachol—glaucoma	0.0316	0.0348	CbGbCtD
Methotrimeprazine—ADRA2A—Dipivefrin—glaucoma	0.0302	0.0333	CbGbCtD
Methotrimeprazine—CHRM2—Pilocarpine—glaucoma	0.0293	0.0324	CbGbCtD
Methotrimeprazine—ADRA1A—Dipivefrin—glaucoma	0.029	0.032	CbGbCtD
Methotrimeprazine—ADRA1D—Clonidine—glaucoma	0.0262	0.0289	CbGbCtD
Methotrimeprazine—ADRA2C—Clonidine—glaucoma	0.0238	0.0263	CbGbCtD
Methotrimeprazine—ADRA2B—Clonidine—glaucoma	0.0226	0.0249	CbGbCtD
Methotrimeprazine—CYP2E1—Pilocarpine—glaucoma	0.0225	0.0248	CbGbCtD
Methotrimeprazine—ADRA1B—Clonidine—glaucoma	0.0191	0.021	CbGbCtD
Methotrimeprazine—ADRA2A—Clonidine—glaucoma	0.0157	0.0173	CbGbCtD
Methotrimeprazine—CYP2E1—Methazolamide—glaucoma	0.0152	0.0167	CbGbCtD
Methotrimeprazine—ADRA1A—Clonidine—glaucoma	0.0151	0.0166	CbGbCtD
Methotrimeprazine—CYP2D6—Carteolol—glaucoma	0.0141	0.0156	CbGbCtD
Methotrimeprazine—CYP1A2—Betaxolol—glaucoma	0.0116	0.0128	CbGbCtD
Methotrimeprazine—CYP2D6—Betaxolol—glaucoma	0.00954	0.0105	CbGbCtD
Methotrimeprazine—CYP2D6—Methazolamide—glaucoma	0.00723	0.00797	CbGbCtD
Methotrimeprazine—CYP1A2—Clonidine—glaucoma	0.00634	0.00699	CbGbCtD
Methotrimeprazine—CYP2D6—Timolol—glaucoma	0.00614	0.00677	CbGbCtD
Methotrimeprazine—CYP2D6—Clonidine—glaucoma	0.00522	0.00576	CbGbCtD
Methotrimeprazine—Photosensitivity—Methazolamide—glaucoma	0.00159	0.0487	CcSEcCtD
Methotrimeprazine—Tachycardia—Dipivefrin—glaucoma	0.00142	0.0435	CcSEcCtD
Methotrimeprazine—Drowsiness—Diclofenamide—glaucoma	0.00117	0.0358	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Methazolamide—glaucoma	0.0011	0.0337	CcSEcCtD
Methotrimeprazine—Photosensitivity—Acetazolamide—glaucoma	0.0011	0.0337	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Diclofenamide—glaucoma	0.00109	0.0334	CcSEcCtD
Methotrimeprazine—Drowsiness—Methazolamide—glaucoma	0.00107	0.0329	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Dipivefrin—glaucoma	0.00107	0.0328	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Methazolamide—glaucoma	0.001	0.0307	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Acetazolamide—glaucoma	0.000762	0.0233	CcSEcCtD
Methotrimeprazine—Drowsiness—Acetazolamide—glaucoma	0.000744	0.0228	CcSEcCtD
Methotrimeprazine—Somnolence—Metipranolol—glaucoma	0.000727	0.0223	CcSEcCtD
Methotrimeprazine—Drowsiness—Brimonidine—glaucoma	0.000714	0.0219	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Acetazolamide—glaucoma	0.000694	0.0213	CcSEcCtD
Methotrimeprazine—Somnolence—Diclofenamide—glaucoma	0.000662	0.0203	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Pilocarpine—glaucoma	0.00066	0.0202	CcSEcCtD
Methotrimeprazine—Constipation—Diclofenamide—glaucoma	0.000637	0.0195	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Dorzolamide—glaucoma	0.000636	0.0195	CcSEcCtD
Methotrimeprazine—Urinary retention—Clonidine—glaucoma	0.000635	0.0195	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Clonidine—glaucoma	0.00061	0.0187	CcSEcCtD
Methotrimeprazine—Somnolence—Methazolamide—glaucoma	0.000609	0.0187	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Metipranolol—glaucoma	0.000602	0.0185	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Carteolol—glaucoma	0.000558	0.0171	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Levobunolol—glaucoma	0.000527	0.0162	CcSEcCtD
Methotrimeprazine—Weight increased—Clonidine—glaucoma	0.000525	0.0161	CcSEcCtD
Methotrimeprazine—Drowsiness—Clonidine—glaucoma	0.000515	0.0158	CcSEcCtD
Methotrimeprazine—Somnolence—Apraclonidine—glaucoma	0.000472	0.0145	CcSEcCtD
Methotrimeprazine—Weight increased—Betaxolol—glaucoma	0.000457	0.014	CcSEcCtD
Methotrimeprazine—Somnolence—Bimatoprost—glaucoma	0.000457	0.014	CcSEcCtD
Methotrimeprazine—Constipation—Apraclonidine—glaucoma	0.000454	0.0139	CcSEcCtD
Methotrimeprazine—Tachycardia—Brimonidine—glaucoma	0.000444	0.0136	CcSEcCtD
Methotrimeprazine—Tachycardia—Travoprost—glaucoma	0.000423	0.013	CcSEcCtD
Methotrimeprazine—Somnolence—Acetazolamide—glaucoma	0.000422	0.0129	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Betaxolol—glaucoma	0.000418	0.0128	CcSEcCtD
Methotrimeprazine—Tachycardia—Brinzolamide—glaucoma	0.000417	0.0128	CcSEcCtD
Methotrimeprazine—Somnolence—Brimonidine—glaucoma	0.000405	0.0124	CcSEcCtD
Methotrimeprazine—Tachycardia—Pilocarpine—glaucoma	0.000401	0.0123	CcSEcCtD
Methotrimeprazine—DRD5—eyelid—glaucoma	0.000398	0.675	CbGeAlD
Methotrimeprazine—Hypersensitivity—Apraclonidine—glaucoma	0.000391	0.012	CcSEcCtD
Methotrimeprazine—Somnolence—Dorzolamide—glaucoma	0.000387	0.0119	CcSEcCtD
Methotrimeprazine—Somnolence—Brinzolamide—glaucoma	0.00038	0.0117	CcSEcCtD
Methotrimeprazine—Constipation—Travoprost—glaucoma	0.00037	0.0114	CcSEcCtD
Methotrimeprazine—Somnolence—Pilocarpine—glaucoma	0.000365	0.0112	CcSEcCtD
Methotrimeprazine—Constipation—Pilocarpine—glaucoma	0.000351	0.0108	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Timolol—glaucoma	0.000342	0.0105	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Brimonidine—glaucoma	0.000335	0.0103	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Dorzolamide—glaucoma	0.00032	0.00982	CcSEcCtD
Methotrimeprazine—Tachycardia—Clonidine—glaucoma	0.00032	0.00982	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Travoprost—glaucoma	0.000319	0.00978	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Brinzolamide—glaucoma	0.000315	0.00966	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Pilocarpine—glaucoma	0.000303	0.00928	CcSEcCtD
Methotrimeprazine—Somnolence—Clonidine—glaucoma	0.000292	0.00894	CcSEcCtD
Methotrimeprazine—Constipation—Clonidine—glaucoma	0.000281	0.0086	CcSEcCtD
Methotrimeprazine—Tachycardia—Betaxolol—glaucoma	0.000279	0.00855	CcSEcCtD
Methotrimeprazine—Constipation—Betaxolol—glaucoma	0.000244	0.00749	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Clonidine—glaucoma	0.000242	0.00741	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Betaxolol—glaucoma	0.00021	0.00645	CcSEcCtD
Methotrimeprazine—Somnolence—Timolol—glaucoma	0.000207	0.00636	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Timolol—glaucoma	0.000172	0.00527	CcSEcCtD
Methotrimeprazine—CHRM5—eye—glaucoma	3.97e-05	0.0674	CbGeAlD
Methotrimeprazine—HTR2A—endothelium—glaucoma	2.69e-05	0.0456	CbGeAlD
Methotrimeprazine—DRD2—eye—glaucoma	2e-05	0.0339	CbGeAlD
Methotrimeprazine—DRD2—retina—glaucoma	1.98e-05	0.0336	CbGeAlD
Methotrimeprazine—HRH1—eye—glaucoma	1.58e-05	0.0268	CbGeAlD
Methotrimeprazine—HRH1—connective tissue—glaucoma	1.52e-05	0.0258	CbGeAlD
Methotrimeprazine—ADRA2A—connective tissue—glaucoma	1.49e-05	0.0254	CbGeAlD
Methotrimeprazine—HTR2A—eye—glaucoma	1.32e-05	0.0224	CbGeAlD
Methotrimeprazine—HTR2A—retina—glaucoma	1.31e-05	0.0222	CbGeAlD
Methotrimeprazine—HTR2A—connective tissue—glaucoma	1.27e-05	0.0216	CbGeAlD
Methotrimeprazine—HRH1—Signaling Pathways—NTRK1—glaucoma	8.42e-06	0.000141	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NTRK1—glaucoma	8.39e-06	0.000141	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NTRK1—glaucoma	8.37e-06	0.00014	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—EDN1—glaucoma	8.36e-06	0.00014	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—BAD—glaucoma	8.34e-06	0.00014	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NTRK1—glaucoma	8.29e-06	0.000139	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NTRK1—glaucoma	8.26e-06	0.000138	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—EDN1—glaucoma	8.23e-06	0.000138	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—NGF—glaucoma	8.22e-06	0.000138	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—GSTT1—glaucoma	8.21e-06	0.000138	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.19e-06	0.000137	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Hemostasis—TP53—glaucoma	8.18e-06	0.000137	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—APOE—glaucoma	8.17e-06	0.000137	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—APOE—glaucoma	8.13e-06	0.000136	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.11e-06	0.000136	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CAV1—glaucoma	8.1e-06	0.000136	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—FN1—glaucoma	8.09e-06	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NGFR—glaucoma	8.08e-06	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—APOE—glaucoma	8.06e-06	0.000135	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—APOE—glaucoma	8.06e-06	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—CAV1—glaucoma	8.06e-06	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—GSTM1—glaucoma	8.03e-06	0.000134	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—BAD—glaucoma	7.99e-06	0.000134	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CAV1—glaucoma	7.99e-06	0.000134	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CAV1—glaucoma	7.99e-06	0.000134	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—CDKN1B—glaucoma	7.98e-06	0.000134	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CDKN2B—glaucoma	7.9e-06	0.000132	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—NGF—glaucoma	7.9e-06	0.000132	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—C3—glaucoma	7.82e-06	0.000131	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CDKN2B—glaucoma	7.78e-06	0.00013	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CDKN2B—glaucoma	7.76e-06	0.00013	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CDKN2B—glaucoma	7.74e-06	0.00013	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—MTHFR—glaucoma	7.73e-06	0.000129	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CDKN2B—glaucoma	7.71e-06	0.000129	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—FN1—glaucoma	7.7e-06	0.000129	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—NGF—glaucoma	7.68e-06	0.000129	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NTRK1—glaucoma	7.68e-06	0.000129	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CDKN2B—glaucoma	7.64e-06	0.000128	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	7.62e-06	0.000128	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—BAD—glaucoma	7.61e-06	0.000128	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—FN1—glaucoma	7.6e-06	0.000127	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—FN1—glaucoma	7.6e-06	0.000127	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—EDN1—glaucoma	7.58e-06	0.000127	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—NGF—glaucoma	7.56e-06	0.000127	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—BAD—glaucoma	7.51e-06	0.000126	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—BAD—glaucoma	7.51e-06	0.000126	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—C3—glaucoma	7.51e-06	0.000126	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—EDN1—glaucoma	7.46e-06	0.000125	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—EDN1—glaucoma	7.45e-06	0.000125	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—EDN1—glaucoma	7.42e-06	0.000124	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—EDN1—glaucoma	7.4e-06	0.000124	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—MMP9—glaucoma	7.39e-06	0.000124	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—GSTM1—glaucoma	7.37e-06	0.000123	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—EDN1—glaucoma	7.33e-06	0.000123	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—EDN1—glaucoma	7.31e-06	0.000122	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—C3—glaucoma	7.3e-06	0.000122	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—APOE—glaucoma	7.28e-06	0.000122	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CAV1—glaucoma	7.21e-06	0.000121	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—APOE—glaucoma	7.2e-06	0.000121	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—C3—glaucoma	7.19e-06	0.00012	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—CAV1—glaucoma	7.13e-06	0.000119	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—MTHFR—glaucoma	7.09e-06	0.000119	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	7.08e-06	0.000119	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—APOE—glaucoma	6.99e-06	0.000117	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NGF—glaucoma	6.97e-06	0.000117	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GSTT1—glaucoma	6.96e-06	0.000117	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CAV1—glaucoma	6.93e-06	0.000116	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—FN1—glaucoma	6.86e-06	0.000115	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NGF—glaucoma	6.86e-06	0.000115	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NGF—glaucoma	6.84e-06	0.000115	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NGF—glaucoma	6.82e-06	0.000114	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NGF—glaucoma	6.8e-06	0.000114	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—NOS3—glaucoma	6.8e-06	0.000114	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—APOE—glaucoma	6.8e-06	0.000114	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—EDN1—glaucoma	6.79e-06	0.000114	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—BAD—glaucoma	6.78e-06	0.000114	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CAV1—glaucoma	6.74e-06	0.000113	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NGF—glaucoma	6.73e-06	0.000113	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NGF—glaucoma	6.72e-06	0.000112	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—NOS3—glaucoma	6.71e-06	0.000112	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—APOE—glaucoma	6.69e-06	0.000112	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Hemostasis—TP53—glaucoma	6.64e-06	0.000111	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—VEGFA—glaucoma	6.64e-06	0.000111	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CAV1—glaucoma	6.63e-06	0.000111	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—C3—glaucoma	6.63e-06	0.000111	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—APOE—glaucoma	6.6e-06	0.000111	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—FN1—glaucoma	6.59e-06	0.00011	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—CAV1—glaucoma	6.54e-06	0.00011	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CYP1B1—glaucoma	6.54e-06	0.00011	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—ABCA1—glaucoma	6.54e-06	0.00011	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—C3—glaucoma	6.52e-06	0.000109	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—MTHFR—glaucoma	6.51e-06	0.000109	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—BAD—glaucoma	6.51e-06	0.000109	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—C3—glaucoma	6.51e-06	0.000109	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—C3—glaucoma	6.48e-06	0.000109	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—C3—glaucoma	6.46e-06	0.000108	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—NOS3—glaucoma	6.42e-06	0.000108	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—FN1—glaucoma	6.41e-06	0.000107	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—C3—glaucoma	6.4e-06	0.000107	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—C3—glaucoma	6.38e-06	0.000107	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—BAD—glaucoma	6.34e-06	0.000106	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—FN1—glaucoma	6.31e-06	0.000106	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NGF—glaucoma	6.24e-06	0.000105	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—BAD—glaucoma	6.23e-06	0.000104	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—APOE—glaucoma	6.17e-06	0.000103	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—NOS3—glaucoma	6.12e-06	0.000103	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CAV1—glaucoma	6.11e-06	0.000102	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—NOS3—glaucoma	6.09e-06	0.000102	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—APOE—glaucoma	6.07e-06	0.000102	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—APOE—glaucoma	6.06e-06	0.000102	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—APOE—glaucoma	6.06e-06	0.000101	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—NOS3—glaucoma	6.04e-06	0.000101	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—NOS3—glaucoma	6.04e-06	0.000101	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—APOE—glaucoma	6.04e-06	0.000101	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—APOE—glaucoma	6.02e-06	0.000101	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CAV1—glaucoma	6.01e-06	0.000101	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—CAV1—glaucoma	6.01e-06	0.000101	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CAV1—glaucoma	6e-06	0.000101	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CAV1—glaucoma	5.98e-06	0.0001	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CAV1—glaucoma	5.96e-06	9.99e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—APOE—glaucoma	5.96e-06	9.98e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—APOE—glaucoma	5.94e-06	9.95e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—C3—glaucoma	5.93e-06	9.94e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CAV1—glaucoma	5.9e-06	9.89e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—CDKN1B—glaucoma	5.89e-06	9.87e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CAV1—glaucoma	5.89e-06	9.86e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—FN1—glaucoma	5.82e-06	9.74e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—CDKN1B—glaucoma	5.81e-06	9.73e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—BAD—glaucoma	5.75e-06	9.63e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—FN1—glaucoma	5.72e-06	9.59e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—FN1—glaucoma	5.71e-06	9.57e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—FN1—glaucoma	5.69e-06	9.54e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—FN1—glaucoma	5.68e-06	9.51e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—BAD—glaucoma	5.66e-06	9.47e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—BAD—glaucoma	5.64e-06	9.45e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—BAD—glaucoma	5.63e-06	9.42e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—FN1—glaucoma	5.62e-06	9.41e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.61e-06	9.39e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—BAD—glaucoma	5.61e-06	9.39e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—FN1—glaucoma	5.6e-06	9.39e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PTGS2—glaucoma	5.57e-06	9.33e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—CDKN1B—glaucoma	5.56e-06	9.32e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—BAD—glaucoma	5.55e-06	9.3e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—ABCA1—glaucoma	5.54e-06	9.28e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CYP1B1—glaucoma	5.54e-06	9.28e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—BAD—glaucoma	5.54e-06	9.28e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—APOE—glaucoma	5.52e-06	9.25e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CAV1—glaucoma	5.47e-06	9.16e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MMP9—glaucoma	5.46e-06	9.14e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—NOS3—glaucoma	5.45e-06	9.13e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—NOS3—glaucoma	5.39e-06	9.03e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MMP9—glaucoma	5.38e-06	9.01e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CDKN1B—glaucoma	5.3e-06	8.88e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—NOS3—glaucoma	5.24e-06	8.77e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CDKN1B—glaucoma	5.23e-06	8.76e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CDKN1B—glaucoma	5.23e-06	8.76e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—GSTM1—glaucoma	5.23e-06	8.76e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—FN1—glaucoma	5.21e-06	8.72e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MMP9—glaucoma	5.15e-06	8.63e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—BAD—glaucoma	5.15e-06	8.62e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—NOS3—glaucoma	5.09e-06	8.53e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—TP53—glaucoma	5.01e-06	8.4e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—NOS3—glaucoma	5.01e-06	8.4e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—NOS3—glaucoma	4.95e-06	8.29e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PTGS2—glaucoma	4.93e-06	8.26e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MMP9—glaucoma	4.91e-06	8.23e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—VEGFA—glaucoma	4.9e-06	8.2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MMP9—glaucoma	4.85e-06	8.12e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MMP9—glaucoma	4.85e-06	8.12e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—VEGFA—glaucoma	4.83e-06	8.09e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CDKN1B—glaucoma	4.72e-06	7.91e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—VEGFA—glaucoma	4.63e-06	7.75e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—MTHFR—glaucoma	4.62e-06	7.74e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NOS3—glaucoma	4.62e-06	7.74e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NOS3—glaucoma	4.55e-06	7.62e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—NOS3—glaucoma	4.54e-06	7.61e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NOS3—glaucoma	4.54e-06	7.6e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CDKN1B—glaucoma	4.54e-06	7.6e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PTGS2—glaucoma	4.52e-06	7.58e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NOS3—glaucoma	4.52e-06	7.58e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NOS3—glaucoma	4.51e-06	7.55e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NOS3—glaucoma	4.46e-06	7.48e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NOS3—glaucoma	4.45e-06	7.46e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GSTM1—glaucoma	4.43e-06	7.42e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CDKN1B—glaucoma	4.41e-06	7.39e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—VEGFA—glaucoma	4.41e-06	7.39e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MMP9—glaucoma	4.37e-06	7.33e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—VEGFA—glaucoma	4.35e-06	7.29e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—VEGFA—glaucoma	4.35e-06	7.29e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CDKN1B—glaucoma	4.34e-06	7.27e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—APOE—glaucoma	4.3e-06	7.21e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CAV1—glaucoma	4.26e-06	7.14e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MMP9—glaucoma	4.2e-06	7.04e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTGS2—glaucoma	4.16e-06	6.96e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NOS3—glaucoma	4.14e-06	6.93e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MMP9—glaucoma	4.09e-06	6.84e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MMP9—glaucoma	4.02e-06	6.74e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CDKN1B—glaucoma	4e-06	6.71e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CDKN1B—glaucoma	3.94e-06	6.6e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CDKN1B—glaucoma	3.93e-06	6.58e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—VEGFA—glaucoma	3.93e-06	6.58e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CDKN1B—glaucoma	3.92e-06	6.56e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—MTHFR—glaucoma	3.92e-06	6.56e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CDKN1B—glaucoma	3.91e-06	6.54e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CDKN1B—glaucoma	3.87e-06	6.48e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	3.86e-06	6.46e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—VEGFA—glaucoma	3.77e-06	6.32e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MMP9—glaucoma	3.71e-06	6.21e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TP53—glaucoma	3.7e-06	6.2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—VEGFA—glaucoma	3.67e-06	6.15e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TP53—glaucoma	3.65e-06	6.12e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MMP9—glaucoma	3.65e-06	6.11e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—APOE—glaucoma	3.65e-06	6.11e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MMP9—glaucoma	3.64e-06	6.1e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MMP9—glaucoma	3.63e-06	6.08e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MMP9—glaucoma	3.62e-06	6.06e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CAV1—glaucoma	3.61e-06	6.05e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—VEGFA—glaucoma	3.61e-06	6.05e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	3.58e-06	6e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MMP9—glaucoma	3.58e-06	6e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MMP9—glaucoma	3.57e-06	5.98e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TP53—glaucoma	3.5e-06	5.86e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TP53—glaucoma	3.33e-06	5.58e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—VEGFA—glaucoma	3.33e-06	5.58e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MMP9—glaucoma	3.32e-06	5.56e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TP53—glaucoma	3.29e-06	5.51e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TP53—glaucoma	3.29e-06	5.51e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—VEGFA—glaucoma	3.28e-06	5.49e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—VEGFA—glaucoma	3.27e-06	5.48e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—VEGFA—glaucoma	3.26e-06	5.46e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—VEGFA—glaucoma	3.25e-06	5.44e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—NOS3—glaucoma	3.22e-06	5.4e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—VEGFA—glaucoma	3.22e-06	5.39e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—VEGFA—glaucoma	3.21e-06	5.37e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—VEGFA—glaucoma	2.98e-06	4.99e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TP53—glaucoma	2.97e-06	4.97e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTGS2—glaucoma	2.95e-06	4.94e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TP53—glaucoma	2.85e-06	4.77e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TP53—glaucoma	2.77e-06	4.64e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—NOS3—glaucoma	2.73e-06	4.57e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TP53—glaucoma	2.73e-06	4.57e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TP53—glaucoma	2.52e-06	4.21e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTGS2—glaucoma	2.5e-06	4.18e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TP53—glaucoma	2.48e-06	4.15e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TP53—glaucoma	2.47e-06	4.14e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TP53—glaucoma	2.46e-06	4.12e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TP53—glaucoma	2.45e-06	4.11e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TP53—glaucoma	2.43e-06	4.07e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TP53—glaucoma	2.42e-06	4.06e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TP53—glaucoma	2.25e-06	3.77e-05	CbGpPWpGaD
